Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Quality measurers of therapeutic communities for substance dependence: an international collaborative study survey in Latin America.

Gómez-Restrepo C, Maldonado P, Rodríguez N, Ruiz-Gaviria R, Escalante MÁ, Gómez RÁ, de Araujo MR, de Oliveira ACS, Rivera JSC, García JAG, Ferrand MP, Blitchtein-Winicki D.

Subst Abuse Treat Prev Policy. 2017 Dec 20;12(1):53. doi: 10.1186/s13011-017-0129-y.

2.

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study.

Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, Thabane L, Samaan Z.

Neuropsychiatr Dis Treat. 2017 May 24;13:1399-1408. doi: 10.2147/NDT.S129480. eCollection 2017.

3.

Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.

Ali B, Green KM, Daughters SB, Lejuez CW.

Addict Behav. 2017 Oct;73:99-104. doi: 10.1016/j.addbeh.2017.04.016. Epub 2017 Apr 27.

PMID:
28500908
4.

Quality of life improvement in Latinas receiving combined substance use disorders and trauma-specific treatment: a cohort evaluation report.

Cruz-Feliciano MA, Miranda-Díaz C, Fernández-Santos DM, Orobitg-Brenes D, Hunter-Mellado RF, Carrión-González IS.

Health Qual Life Outcomes. 2017 May 2;15(1):90. doi: 10.1186/s12955-017-0667-z.

5.

Daily stressors as antecedents, correlates, and consequences of alcohol and drug use and cravings in community-based offenders.

Neupert SD, Desmarais SL, Gray JS, Cohn AM, Doherty S, Knight K.

Psychol Addict Behav. 2017 May;31(3):315-325. doi: 10.1037/adb0000276. Epub 2017 Apr 6.

PMID:
28383933
6.

Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes.

Lui CK, Sterling SA, Chi FW, Lu Y, Campbell CI.

Addict Behav. 2017 May;68:45-51. doi: 10.1016/j.addbeh.2017.01.010. Epub 2017 Jan 6.

PMID:
28088743
7.

Neural responses to negative outcomes predict success in community-based substance use treatment.

Forster SE, Finn PR, Brown JW.

Addiction. 2017 May;112(5):884-896. doi: 10.1111/add.13734. Epub 2017 Feb 3.

PMID:
28029198
8.

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.

Bhatt M, Zielinski L, Baker-Beal L, Bhatnagar N, Mouravska N, Laplante P, Worster A, Thabane L, Samaan Z.

Syst Rev. 2016 Nov 14;5(1):189.

9.

Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan.

Sheikh Fathollahi M, Torkashvand F, Najmeddin H, Rezaeian M.

Int J High Risk Behav Addict. 2016 Jul 17;5(3):e29121. eCollection 2016 Sep.

10.

Patient-centered methadone treatment: a randomized clinical trial.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Gandhi D, Olsen Y, Jaffe JH.

Addiction. 2017 Mar;112(3):454-464. doi: 10.1111/add.13622. Epub 2016 Nov 10.

PMID:
27661788
11.

Brain potentials predict substance abuse treatment completion in a prison sample.

Fink BC, Steele VR, Maurer MJ, Fede SJ, Calhoun VD, Kiehl KA.

Brain Behav. 2016 May 31;6(8):e00501. doi: 10.1002/brb3.501. eCollection 2016 Aug.

12.

Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).

Roux P, Lions C, Vilotitch A, Michel L, Mora M, Maradan G, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group.

Harm Reduct J. 2016 Apr 5;13:12. doi: 10.1186/s12954-016-0100-7.

13.

Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.

Bach P, Wood E, Dong H, Guillemi S, Kerr T, Montaner J, Milloy MJ.

BMC Infect Dis. 2015 Nov 19;15:537. doi: 10.1186/s12879-015-1255-7.

14.

Development and psychometric validation of a novel patient survey to assess perceived quality of substance abuse treatment in South Africa.

Myers B, Govender R, Koch JR, Manderscheid R, Johnson K, Parry CD.

Subst Abuse Treat Prev Policy. 2015 Nov 6;10:44. doi: 10.1186/s13011-015-0040-3.

15.

Resistance to temptation: the interaction of external and internal control on alcohol use during residential treatment for alcohol use disorder.

Soravia LM, Schläfli K, Stutz S, Rösner S, Moggi F.

Alcohol Clin Exp Res. 2015 Nov;39(11):2209-14. doi: 10.1111/acer.12880. Epub 2015 Oct 7.

16.

Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Stein MD, Anderson BJ, Bailey GL.

J Subst Abuse Treat. 2015 Dec;59:99-103. doi: 10.1016/j.jsat.2015.07.002. Epub 2015 Jul 14.

17.

The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City.

Ompad DC, Benjamin EO, Weiss L, Palamar JJ, Galea S, Wang J, Vlahov D.

J Urban Health. 2015 Oct;92(5):955-65. doi: 10.1007/s11524-015-9973-0.

18.

Prediction of HIV Sexual Risk Behaviors Among Disadvantaged African American Adults Using a Syndemic Conceptual Framework.

Nehl EJ, Klein H, Sterk CE, Elifson KW.

AIDS Behav. 2016 Feb;20(2):449-60. doi: 10.1007/s10461-015-1134-7.

19.

Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O'Grady KE, Jaffe JH.

J Addict Dis. 2015;34(2-3):151-61. doi: 10.1080/10550887.2015.1059222.

20.

Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.

Clark RE, Baxter JD, Aweh G, O'Connell E, Fisher WH, Barton BA.

J Subst Abuse Treat. 2015 Oct;57:75-80. doi: 10.1016/j.jsat.2015.05.001. Epub 2015 May 7.

Supplemental Content

Support Center